Blood Glucose Monitoring Market is estimated to be 19.6 Billion by 2029 with a CAGR of 6.6% during the forecasted period.


Blood glucose monitoring is the process of testing the diabetes level within the blood. It helps to acknowledge the glucose level of blood within the required target range. Blood sugar monitoring devices provide useful insight to manage diabetes. It helps to trace the progress of treatment goal also as observe the effect of medication on blood glucose level and understand how ailment affects the glucose level within the blood. The global blood glucose monitoring market accounted for US$ 11.10 billion in 2020 and is estimated to be US$ 19.6 billion by 2029 and is anticipated to register a CAGR of 6.6.

The report "Global Blood Glucose Monitoring Market, By Type (Self-Monitoring Blood Glucose and Continuous Blood Glucose Monitoring), By Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Receivers)and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

  • In August 2016, Roche launched the Accu-Chek Guide blood glucose monitoring system. The device is designed to make daily glucose monitoring easy.
  • In October 2018, Platinum Equity acquired Lifescan from Johnson & Johnson diabetes care business, with an aim to increase its product offering.
  • In August 2018, Dexcom acquired TypeZero Technologies, which was an extension of long partnership between both companies with an aim to improve its product offering through TypeZero Technologies automated insulin delivery system.

Analyst View:

Rising incidence of diabetes, coupled with increasing geriatric population prone to diabetes is the key factors to drive the market growth. According to the International Diabetes Federation, approximately 424 million people were living with diabetes in 2017 and this number is expected to reach 629 million by 2045. Increasing geriatric population is also propelling the market. According to the World Health Organization (WHO), the global aging population will rise from 12% in 2015 to 22% by 2050. This translates into significant development potential.

The market has significantly benefited from continuous technological advancements and early detection of hypo and hyperglycemic diabetes. Rapidly changing lifestyles, such as smoking and consumption of alcohol and unhealthy foods, are contributing to the rise in the number of diabetes patients worldwide. Obesity is also one of the major factors contributing to diabetes. According to WHO, over 650 million people were obese in 2016 and this number is expected to grow further during the forecast period.

Key Market Insights from the report:        

The global blood glucose monitoring market accounted for 11.0 billion in 2020 and is estimated to be US$ 19.6 billion by 2029 and is anticipated to register a CAGR of 6.6%. The market report has been segmented on the basis of type, component and region.

  • Depending upon type, the self-monitoring blood glucose segment is projected to grow at highest CAGR over the forecast period owing to its ease of use and low cost.
  • Depending upon component, the test strips and lancets segment is projected to grow at highest CAGR over the forecast period.
  • By region, North America has been leading the global market owing to its well-established healthcare sector. Increasing prevalence of obesity and high cost of treatment is also expected to drive the region, along with technological advancements and new product launches.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3947

Competitive Landscape:

The prominent player operating in the global blood glucose monitoring market includes Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche Ltd, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical Holding plc., Dexcom, Inc., and LifeScan, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Comments

Popular posts from this blog

Monkeypox Disease Diagnostics Market - The abrupt global expansion of the monkeypox virus has increased the demand for monkeypox diagnostics.

Humanized Liver Mice Model Market is estimated to be US$ 133.72 billion by 2030 with a CAGR of 5.30% during the forecast period

Bipolar Disorder Market is estimated to be US$ 6.7 billion by 2030 with a CAGR of 2.3% during the forecast period